Circulating tumor DNA in patients with colorectal adenomas: assessment of detectability and genetic heterogeneity-Reference-Cited by-同舟云学术

Circulating tumor DNA in patients with colorectal adenomas: assessment of detectability and genetic heterogeneity

Published:2018-08-30 Issue:9 Volume:9 Page:
ISSN:2041-4889
Container-title:Cell Death & Disease
language:en
Short-container-title:Cell Death Dis

Author:

Myint Ni Ni Moe,Verma Ajay M.,Fernandez-Garcia Daniel,Sarmah Panchali,Tarpey Patrick S.,Al-Aqbi Saif Sattar,Cai Hong,Trigg Ricky^ORCID,West Kevin,Howells Lynne M.,Thomas Anne,Brown Karen,Guttery David S.^ORCID,Singh Baljit,Pringle Howard J.,McDermott Ultan,Shaw Jacqui A.,Rufini Alessandro

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Cell Biology,Cellular and Molecular Neuroscience,Immunology

Link

http://www.nature.com/articles/s41419-018-0934-x.pdf

Reference61 articles.

1. Siegel, R. L. et al. Colorectal cancer statistics, 2017. CA Cancer J. Clin. 67, 177–193 (2017).

2. Fearon, E. R. & Vogelstein, B. A genetic model for colorectal tumorigenesis. Cell 61, 759–767 (1990).

3. Jass, J. R. Classification of colorectal cancer based on correlation of clinical, morphological and molecular features. Histopathology 50, 113–130 (2007).

4. Sottoriva, A. et al. A Big Bang model of human colorectal tumor growth. Nat. Genet. 47, 209–216 (2015).

5. Uchi, R. et al. Integrated multiregional analysis proposing a new model of colorectal cancer evolution. PLoS Genet. 12, e1005778 (2016).

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An investigation of plasma cell-free RNA for the detection of colorectal cancer: From transcriptome marker selection to targeted validation;PLOS ONE;2024-08-15

2. Plasma mutation profile of precursor lesions and colorectal cancer using the Oncomine Colon cfDNA Assay;2024-08-10

3. Ultrasensitive plasma-based monitoring of tumor burden using machine-learning-guided signal enrichment;Nature Medicine;2024-06

4. The Potential of Cell-Free DNA in Cancer: towards Standardization and Optimization for Enhanced Diagnosis and Monitoring;J BIOL REG HOMEOS AG;2024

5. No BRAF p.V600E mutation detection in ameloblastoma liquid biopsy-based analysis by ddPCR;Oral Oncology;2024-02